Ascendis Pharma A/S (ASND) said that it has commenced an underwritten public offering of $300 million of American Depositary Shares or "ADSs", each of which represents one ordinary share of Ascendis.
In addition, the company said it expects to grant the underwriters a 30-day option to purchase up to an additional $45 million of ADSs at the public offering price, less the underwriting commissions.
The offering is subject to market and other conditions.
J.P. Morgan, Morgan Stanley, Evercore ISI and Goldman Sachs & Co. LLC are acting as joint book-running managers for the proposed offering.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.